tivantinib
Showing 1 - 25 of 30
Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))
Completed
- Colorectal Cancer Metastatic
- C-met Overexpression
- Tivantinib (ARQ197)
-
Rozzano, Milano, ItalyIstituto Clinico Humanitas
Sep 8, 2022
Advanced Solid Tumors Trial (Tivantinib, Anti-Cancer Combination Therapy)
Completed
- Advanced Solid Tumors
- Tivantinib
- Anti-Cancer Combination Therapy
- (no location specified)
Feb 17, 2021
Malignant Pleural Mesothelioma, Nonsquamous Nonsmall Cell Tumor of Lung Trial in Rozzano (Tivantinib)
Completed
- Malignant Pleural Mesothelioma
- Nonsquamous Nonsmall Cell Neoplasm of Lung
- Tivantinib
-
Rozzano, Milan, ItalyIstituto Clinico Humanitas
Jan 20, 2021
Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas) Trial in France, United Kingdom, United States (Tivantinib (ARQ 197))
Terminated
- Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas)
- Tivantinib (ARQ 197)
-
Los Angeles, California
- +9 more
Mar 12, 2021
Sarcoma, Stomach Tumors, Tumors Trial run by the NCI (Pazopanib, ARQ 197)
Completed
- Sarcoma
- +2 more
- Pazopanib
- ARQ 197
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 23, 2021
Hepatocellular Carcinoma Trial in Worldwide (Tivantinib, Placebo)
Completed
- Hepatocellular Carcinoma
- Tivantinib
- Placebo
-
Tucson, Arizona
- +112 more
Mar 12, 2021
Metastatic Colorectal Cancer Trial in Worldwide (Tivantinib, Placebo, Cetuximab)
Completed
- Metastatic Colorectal Cancer
- Tivantinib
- +3 more
-
Beverly Hills, California
- +39 more
Mar 12, 2021
Refractory Multiple Myeloma Trial in Houston (drug, other, procedure)
Completed
- Refractory Multiple Myeloma
- Tivantinib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2019
Non Squamous, Non-small-cell Lung Cancer Trial in Worldwide (Tivantinib, Placebo, Erlotinib)
Terminated
- Non Squamous, Non-small-cell Lung Cancer
- Tivantinib
- +2 more
-
Tucson, Arizona
- +304 more
Mar 12, 2021
Hepatic Impairment, Solid Tumor, Cancer Trial in Los Angeles, Hackensack (Tivantinib)
Completed
- Hepatic Impairment
- +2 more
- Tivantinib
-
Los Angeles, California
- +1 more
Feb 8, 2019
Solid Tumors Trial in San Antonio (Tivantinib, Placebo)
Completed
- Solid Tumors
- Tivantinib
- Placebo
-
San Antonio, TexasSTART - South Texas Accelerated Research Therapeutics, LLC
Feb 8, 2019
Solid Tumors Trial in San Antonio (tivantinib, omeprazole, s-warfarin)
Completed
- Solid Tumors
- tivantinib
- +6 more
-
San Antonio, TexasSTART - South Texas Accelerated Research Therapeutics, LLC
Feb 8, 2019
Solid Tumors Trial in United States (Tivantinib (ARQ 197) Capsule, Tivantinib (ARQ 197) Tablet, Tivantinib (ARQ 197) Capsule D,
Completed
- Solid Tumors
- Tivantinib (ARQ 197) Capsule
- +2 more
-
Santa Monica, California
- +3 more
Feb 8, 2019
Cancer Target Therapy Efficacy
Active, not recruiting
- Cancer
- RNA sequencing
- +5 more
-
Walnut, California
- +6 more
Sep 13, 2021
Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (Laboratory
Completed
- Hormone-Resistant Prostate Cancer
- +3 more
- Laboratory Biomarker Analysis
- +2 more
-
Washington, District of Columbia
- +19 more
Aug 13, 2018
Metastatic NSCLC Trial in United States (ARQ 197 plus erlotinib, Pemetrexed, docetaxel or gemcitabine)
Completed
- Metastatic Non-Small Cell Lung Cancer
- ARQ 197 plus erlotinib
- Pemetrexed, docetaxel or gemcitabine
-
Stanford, California
- +12 more
Mar 5, 2018
Adult Solid Tumor Trial in United States (other, biological, drug)
Completed
- Adult Solid Neoplasm
- Laboratory Biomarker Analysis
- +4 more
-
Duarte, California
- +6 more
Apr 2, 2018
Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (Erlotinib
Completed
- Recurrent Renal Cell Carcinoma
- +4 more
- Erlotinib Hydrochloride
- +2 more
-
Tucson, Arizona
- +213 more
Dec 12, 2018
Solid Tumor Trial in Hershey, Pittsburgh (biological, other, drug)
Completed
- Solid Neoplasm
- Bevacizumab
- +3 more
-
Hershey, Pennsylvania
- +1 more
Oct 11, 2017
Advanced Hepatocellular Carcinoma Trial in Kashiwa-city (ARQ 197)
Completed
- Advanced Hepatocellular Carcinoma
- ARQ 197
-
Kashiwa-city, Chiba, Japan(unnamed)
Feb 28, 2017
Malignant Solid Tumour, Gastroesophageal Cancer Trial in United States (Tivantinib, FOLFOX)
Completed
- Malignant Solid Tumour
- Gastroesophageal Cancer
- Tivantinib
- FOLFOX
-
New Haven, Connecticut
- +8 more
Oct 3, 2016
Epithelioid Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatoid Mesothelioma Trial in United States (Laboratory
Terminated
- Epithelioid Mesothelioma
- +5 more
- Laboratory Biomarker Analysis
- Tivantinib
-
Duarte, California
- +17 more
Aug 26, 2016
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Boston (Laboratory Biomarker Analysis,
Completed
- Estrogen Receptor Negative
- +5 more
- Laboratory Biomarker Analysis
- Tivantinib
-
Boston, Massachusetts
- +1 more
Feb 23, 2016
Non-small-cell Lung Cancer Trial in Osaka, Shizuoka (ARQ 197 and Erlotinib)
Completed
- Non-small-cell Lung Cancer
- ARQ 197 and Erlotinib
-
Osaka, Japan
- +1 more
Mar 14, 2017